Results 141 to 150 of about 1,652 (181)

Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer. [PDF]

BJC Rep
Kong A, Kirkham AJ, Savage JS, Mant R, Lax S, Good J, Forster MD, Sacco JJ, Schipani S, Harrington KJ, Yap C, Mehanna H.   +11 more
europepmc   +1 more source

Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors. [PDF]

Front Pharmacol
Song G, Liu J, Tang X, Zhong J, Zeng Y, Zhang X, Zhou J, Zhou J, Cao L, Zhang Q, Li Y.   +10 more
europepmc   +1 more source

An update of predictive biomarkers related to WEE1 inhibition in cancer therapy. [PDF]

J Cancer Res Clin Oncol
Wang Z, Li W, Li F, Xiao R.
europepmc   +1 more source

Advances in p53 Therapies for Oral Squamous Cell Carcinoma: A Literature Review. [PDF]

Curr Issues Mol Biol
Martínez Aguilar VM, Trejo-Solís C, Magaña-Maldonado R, Chac-Couoh KE, Pitones-Rubio V, Gallardo-Pérez JC, Carrillo Ávila BA, Hurtado-Camarena A, Chávez-Cortéz EG.   +8 more
europepmc   +1 more source

Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. [PDF]

NPJ Precis Oncol
Wang J, Xiu J, Battaglin F, Arai H, Soni S, Zhang W, Goldberg RM, Philip PA, Seeber A, Hwang JJ, Shields AF, Marshall JL, Astaturov I, Liu T, Lockhart AC, Korn WM, Shen L, Lenz HJ.   +17 more
europepmc   +1 more source

Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation. [PDF]

Nat Commun
Yang X, Hu X, Yin J, Li W, Fu Y, Yang B, Fan J, Lu F, Qin T, Kang X, Zhuang X, Li F, Xiao R, Shi T, Song K, Li J, Chen G, Sun C.   +17 more
europepmc   +1 more source

A GCN1-independent activator of the kinase GCN2. [PDF]

Elife
Zhu J, Emanuelli G, Masson GR, Vinciauskaite V, Willems H, Cai P, Lim A, Brown CA, Winpenny D, Clarke M, Gilley R, Preston F, Wilson JCJ, Bader A, Rahman T, Chambers JE, Skidmore J, Morrell NW, Marciniak SJ.   +18 more
europepmc   +1 more source